Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" · Scour

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative ...

How Myelofibrosis Stem Cells Manipulate Their Surroundings

Geron to Participate in 25th Annual Needham Virtual Healthcare Conference

Toth Financial Advisory Corp Buys Stake in Incyte Corporation

JPMorgan BetaBuilders MSCI US REIT ETF declares quarterly distribution of $0.4053

Oncology Drugs Fast-Tracked and Prioritized by the FDA in March 2026

Race Across the World in-laws Mark and Margo open up about death of wife and sister

Secondary Myelofibrosis Market (2026-2033) | Key Aspects and Growth Drivers

Peri-Transplant Ruxolitinib Leads to Low GVHD Incidence in Myelofibrosis

Myelofibrosis no longer a laggard in blood cancer survival thanks to treatment advances

Rare and refractory blood cancers get PBS drug listings

Annual Report 2025 Active Biotech AB (publ)

Cheaper medicines for people fighting cancer and rare diseases

Phase 3 SENTRY Trial Demonstrates Significant Spleen Volume Reduction With Selinexor ...

PBS expands treatment options for rare diseases with April listings

Liv Hospital Expands Advanced STEM CELL Diagnosis and Evaluation Services for ...

Liv Hospital Introduces Advanced STEM CELL Treatment and Procedures Program ...

PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4 ...

CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial

Selinexor Combo Hits Spleen Target, Misses Symptom Endpoint in Myelofibrosis

Log in to enable infinite scrolling